Clinical Trial

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn if concurrent chemoradiotherapy followed by immunotherapy as maintenance therapy works to treat locally advanced esophageal squamous cell cancer in adults.
Protocol Amendment History 1 change
minor Trial arms changed: 2 -> 4 2026-04-18
Trial Details
NCT Number NCT06964568
Lead Sponsor Fudan University
Conditions Esophageal Carcinoma, Radiotherapy, Immunotherapy
Enrollment 452 participants
Start Date 2025-02-01
Primary Completion 2029-02 (estimated)
Study Completion 2031-02 (estimated)
Updated on ClinicalTrials.gov 2026-04-17